
Migraine Science
Choosing the best PRESCRIPTION preventive migraine treatment for you (if you have episodic migraines)!
The below isn't medical advice, but educational knowledge to go prepared with when meeting with your neurologist.
Episodic migraines are migraines that occur less than 15 times per month. Anything more is chronic migraines.
Let’s get to the point so you don’t need to read more information than you want.
There are 4 main categories you should expect to be prescribed if you have episodic migraines.
Beta blockers: metoprolol, propranolol, timolol
Antidepressants (there are two of different classes): Amitriptyline (a TCA) and venlafaxine (an SNRI)
Anticonvulsants: Valproate (valproic acid), topiramate (more commonly known as the brand name Topamax)
CGRP antagonists: Rimegepant, atogepant, fremanezumab, galcanezumab, eptinezumab.
Due to high cost and hurdles health insurance will put you through, at least in the states, CGRP antagonists are generally only prescribed when other classes have failed. (Yes, I know, this is terrible since they generally work well- at least for a period of time).
Now, which medication is chosen for you as a patient? This requires individualized patient care and a good understanding of a patient’s medical history.
Depression? An antidepressant like the ones listed above may be of benefit.
Insomnia? Amitriptyline.
Obesity? Topamax
Autoimmune condition with Raynaud’s or Raynaud’s alone? Calcium channel blockers. Why aren’t they listed above with the other classes? Data isn’t so great.
Does the patient have hypertension and is less than 60 years of age and a nonsmoker? Then going for the beta blockers is best barring no contraindications. (For smokers or over the age of 60, beta blockers may increase the rate of cardiovascular events so a calcium channel blocker may be indicated instead).
Treatment failure or side effects? Switch to another class.
Where to next?
Pick a topic and dive into more free, research-backed guides in the Migraine Resource Hub.
Vestibular Rehabilitation for Vestibular Migraine: What 7 Studies Show
Seven studies and 272 adults with vestibular migraine show a pooled 23.97 point drop in dizziness handicap after vestibular rehabilitation, above the usual threshold for clinical meaningfulness. Balance confidence did...
Read MoreBotox for Chronic Migraine: What 479 Real-World Patients Show
A 479-patient real-world study of onabotulinumtoxinA for chronic migraine found a mean reduction of 5.9 monthly headache days, with 27.3% reaching the 50% response threshold and 41.6% shedding medication overuse....
Read MoreThe New Migraine Prevention Guideline: What the AAN and AHS Recommend
The American Academy of Neurology and the American Headache Society have published a joint practice guideline on migraine prevention in adults: 17 recommendations and 52 statements. It names no single...
Read More








